Literature DB >> 33310128

Plasma levels of interleukin-38 in healthy aging and in type 2 diabetes.

Felicia Gurău1, Andrea Silvestrini1, Giulia Matacchione2, Francesca Fazioli1, Anna Rita Bonfigli3, Fabiola Olivieri4, Jacopo Sabbatinelli1.   

Abstract

Plasma levels of interleukin (IL)-38 were evaluated in patients with type 2 diabetes (T2DM) and healthy controls. Plasma IL-38 was higher in T2DM patients and positively related to waist/hip ratio, HbA1c, uric acid, liver function tests, triglycerides and total proteins. Patients suffering from diabetic nephropathy had the highest IL-38 levels.
Copyright © 2020. Published by Elsevier B.V.

Entities:  

Keywords:  age-related diseases; aging; inflammation; interleukin-38; type 2 diabetes

Year:  2020        PMID： 33310128     DOI： 10.1016/j.diabres.2020.108585

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN： 0168-8227            Impact factor:   5.602


  5 in total

Review 1.  Immunobiological Properties and Clinical Applications of Interleukin-38 for Immune-Mediated Disorders: A Systematic Review Study.

Authors:  Abdolreza Esmaeilzadeh; Nazila Bahmaie; Elham Nouri; Mohammad Javad Hajkazemi; Maryam Zareh Rafie
Journal:  Int J Mol Sci       Date:  2021-11-21       Impact factor: 5.923

2.  Evaluation of interleukin-38 levels in serum of patients with coronavirus disease 2019.

Authors:  Wasan W Al-Bassam; Ibtihal A Al-Karaawi; Inas K Sharquie; Ali H Ad'hiah
Journal:  J Med Virol       Date:  2022-04-14       Impact factor: 20.693

3.  Circulating interleukin-38 concentrations in healthy adults.

Authors:  Lisa U Teufel; Dennis M de Graaf; Mihai G Netea; Charles A Dinarello; Leo A B Joosten; Rob J W Arts
Journal:  Front Immunol       Date:  2022-08-09       Impact factor: 8.786

4.  Serum interleukin-38 levels correlated with insulin resistance, liver injury and lipids in non-alcoholic fatty liver disease.

Authors:  Jun Cao; Lin Hua; Shipei Zhang; Jinping Tang; Fan Ke; Zhouhuan Wu; Guohui Xue
Journal:  Lipids Health Dis       Date:  2022-08-10       Impact factor: 4.315

5.  Randomized, Double-Blind, Placebo-Controlled Trial to Test the Effects of a Nutraceutical Combination Monacolin K-Free on the Lipid and Inflammatory Profile of Subjects with Hypercholesterolemia.

Authors:  Olga Protic; Raffaele Di Pillo; Alberto Montesanto; Roberta Galeazzi; Giulia Matacchione; Angelica Giuliani; Jacopo Sabbatinelli; Felicia Gurău; Andrea Silvestrini; Fabiola Olivieri; Roberto Antonicelli; Anna Rita Bonfigli
Journal:  Nutrients       Date:  2022-07-08       Impact factor: 6.706
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.